Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)
Clinical trial NCT05381948 · COMPLETED
Trial details
- NCT number
- NCT05381948
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2023-11-29
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.